Singapore’s IP premiums are rising again

Singapore’s IP premiums are rising again – here’s what’s really driving it and what to watch next.

If you’ve opened your renewal letter lately and felt your blood pressure go up faster than Medisave interest, you’re not alone.

I’ve been seeing this “vicious circle” in Integrated Shield Plans (IPs) for years, and 2025 is (hopefully) shaping up to be a turning point rather than just another price hike.

Let’s unpack what changed, who’s moving, and why your own plan might need a tune-up before Chinese New Year lo hei.

6 out of 7 IP insurers raised premiums for 2025.

The outlier is Raffles Health Insurance, which didn’t adjust premiums for the second year running, even though it still posted underwriting losses.

Insurers cite 3 big pressures: rising claims in 2024 (up roughly 9% to 27% for most players), medical inflation, and expanded benefits like coverage for high-cost drugs and home-based hospital care.

Income adjusted from 1 Oct: average +4.5% for IPs and +10.8% for IPs with riders, following a swing from a 2023 underwriting profit to a 2024 loss.

Singlife said its portfolio-wide average increase is “more than 10%”, alongside richer benefits such as coverage for cell, tissue and gene therapy products.

HSBC Life tweaked private hospital IP and rider pricing in April and added outpatient and high-cost drug benefits in October.

Prudential raised rider premiums from 1 May and shifted incentives towards panel providers, while extending coverage in October.

AIA revised most IP and rider premiums from 1 Oct and lengthened pre/post-hospitalisation coverage at public hospitals.

Great Eastern increased premiums from 1 Nov, added benefits like higher proton beam therapy limits and stroke recovery, and launched a lower-premium IP that asks members to shoulder more at private hospitals.

Here’s a simple snapshot you can skim.

Under the hood, this year’s benefit upgrades mirror MediShield Life’s wider base coverage for MIC@Home and selected outpatient treatments, plus the inclusion of certain high-cost drugs.

That sounds great for protection, but it also pushes total claims higher.

Regulators have warned about “buffet syndrome” in generous plan designs, and insurers are now trying to nudge behaviour with panel incentives, higher co-pays, and “right-sizing” options that don’t cover every dollar.

The headline isn’t just “premiums up”.

It’s that the market is quietly re-pricing choice and speed.

You still can buy access to private specialists, broader drug lists and faster pathways – but the price tag will increasingly reflect your usage pattern, your doctor panel choice, and your willingness to co-pay.

Three second-order effects to watch:

First, product bifurcation. 

Expect more “value” IPs with noticeably lower premiums but tighter private-hospital terms or higher deductibles.

Great Eastern’s new plan is a template others can copy.

This creates a clearer fork between “pure peace-of-mind at subsidised/public levels” versus “premium access in private settings”.

Second, behaviour-based pricing.

Panel usage, claims-free discounts, and wellness-linked rider rebates are becoming the new levers.

If you insist on non-panel providers, be ready for bigger out-of-pocket amounts before the rider kicks in.

This will subtly corral demand back to managed networks and curb over-servicing.

Third, claims volatility from advanced therapies.

Coverage for high-cost drugs and CTGTPs is clinically meaningful but actuarially tricky.

A handful of claims can swing a portfolio. Insurers will be careful: broader coverage now, but with utilisation controls, medical necessity checks and periodic repricing.

For consumers, that means benefits may continue to evolve – upwards in scope but with sharper rules.

Let’s face it – nobody enjoys paying more for the same coverage.

But in this case, the price hikes come with subtle shifts in what “coverage” really means. And for many Singaporeans, this is the wake-up call to take insurance planning off autopilot.

First, don’t assume “more coverage = better deal.”

Generous riders that once covered 100% of hospital bills are slowly disappearing, and for good reason. They’ve fuelled the “buffet syndrome” – when patients opt for more scans, tests, or premium ward classes simply because they’re not paying out-of-pocket.

That behaviour drives up claims, which then pushes premiums even higher for everyone. In other words, we’ve been stuck in a loop where peace of mind for a few means higher costs for the rest.

Second, rethink how you use your IP.

If you have private-hospital coverage but mostly use public or restructured hospitals, you’re likely overpaying. 

According to MOH data, about half of IP policyholders still end up in subsidised wards even though they’re paying for private coverage. 

That’s like buying business-class tickets every year but flying economy half the time.

A downgrade to a B1/A-ward plan can easily save you hundreds (sometimes thousands) a year while still covering big hospital bills.

Third, look for panel and co-payment options that suit your health and budget.

Insurers are moving towards rewarding disciplined use. Prudential’s and GE’s panel-based designs, for example, can reduce your premiums or waive higher out-of-pocket costs if you stick with partner doctors.

If you value freedom of choice, fine – but factor in that it’ll cost more. The market’s becoming clearer about this trade-off.

Fourth, budget for future jumps. 

Premiums don’t just rise with medical inflation – they spike with age. Many Singaporeans underestimate how sharply premiums climb past age 50, when both claims and chronic illnesses increase.

Review your IP every few years with a trusted advisor.

You can downgrade plans within the same insurer without fresh underwriting, but don’t wait till your health changes – by then, it’s too late to switch.

Finally, remember that the government is nudging us toward shared responsibility. 

Policies that make us pay a small co-payment (say, 5–10%) aren’t “worse deals.” They’re guardrails to keep the system sustainable and our premiums from ballooning out of control.

It’s like paying a token entry fee at an all-you-can-eat buffet – enough to make you think twice before overindulging.

Final thoughts

Singapore’s IP system isn’t broken – it’s just under pressure from its own success. We wanted fast access, more comfort, and full coverage; now we’re paying for that privilege.

Insurers are recalibrating, MOH is tightening benchmarks, and consumers need to right-size expectations.

If there’s one takeaway I always tell my clients it’s this: your insurance plan isn’t a “set-and-forget” product.

It’s a living, evolving contract – one that should grow with your needs, not your fears.

So before your next renewal, ask yourself: Am I paying for peace of mind, or just for comfort I’ll never use?

Stay informed, stay insured, and stay realistic – because the smartest protection is the one that fits you, not the market.